← back to search

Giuseppe Cifelli

University of Padua · IT
Area of research
Cardiology and Cardiovascular Medicine · Pulmonary and Respiratory Medicine
Research interest
Research interests include Biology, Transforming growth factor, Internal medicine, Endocrinology, Chemokine, and Adventitia.
h-index
citations
133
works
3
NIH funding
primary concept
email

Recent publications

Loss of EMILIN-1 Enhances Arteriolar Myogenic Tone Through TGF-β (Transforming Growth Factor-β)–Dependent Transactivation of EGFR (Epidermal Growth Factor Receptor) and Is Relevant for Hypertension in Mice and Humans
Arteriosclerosis Thrombosis and Vascular Biology 2018cited by 28position: middledoi
Targeting Interleukin-1β Protects from Aortic Aneurysms Induced by Disrupted Transforming Growth Factor β Signaling
Immunity 2017cited by 58position: middledoi
Vascular Smooth Muscle Emilin-1 Is a Regulator of Arteriolar Myogenic Response and Blood Pressure
Arteriosclerosis Thrombosis and Vascular Biology 2012cited by 47position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Giorgio M. Bressan · University of Padua3 papers (2012–2018)Giuseppe Lembo · Istituto Neurologico Mediterraneo3 papers (2012–2018)Paola Braghetta · University of Padua3 papers (2012–2018)Dario Bizzotto · University of Padua3 papers (2012–2018)Daniela Carnevale · Istituto Neurologico Mediterraneo3 papers (2012–2018)Francesco Da Ros · University of Padua3 papers (2012–2018) · 2 papers (2017–2018) · 2 papers (2017–2018) · 2 papers (2017–2018)Nicola Facchinello · University of Padua2 papers (2012–2018) · 2 papers (2017–2018)Gaia Litteri · University of Padua1 papers (2012–2012) · 1 papers (2018–2018)Alessandra D’Urso · University of Padua1 papers (2012–2012)Rosario Rizzuto · University of Padua1 papers (2018–2018)Antonio Damato · University of Padua1 papers (2012–2012)Dino Volpin · University of Padua1 papers (2012–2012)Angelo Maffei · University of Padua1 papers (2012–2012) · 1 papers (2017–2017)Patrizia Sabatelli · University of Padua1 papers (2012–2012)